6-甲基-1-萘甲酰氯 | 87700-71-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 6-甲基-1-萘甲酰氯
• 英文名称: 6-methyl-1-naphthoyl chloride
• 英文别名: 6-methylnaphthalene-1-carbonyl chloride
• CAS: 87700-71-8
• 化学式: C₁₂H₉ClO
• 分子量: 204.656
• InChiKey: TWEBOZKXUXHQEX-UHFFFAOYSA-N

物化性质

• 沸点：
  324.9±11.0 °C(Predicted)
• 密度：
  1.231±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2916399090

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  6-甲基萘-1-羧酸	6-Methyl-[1]naphthoesaeure	6315-19-1	C12H10O2	186.21

反应信息

• 作为反应物：
  描述：

  6-甲基-1-萘甲酰氯 在 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 苯 为溶剂， 生成 N,N-diisopropyl 6-methyl-2-(2-phenylallyl)naphthalen-1-amide
  参考文献：
  名称：

  New Synthesis of Vaulted Biaryl Ligands via the Snieckus Phenol Synthesis

  摘要：

  In an effort to develop a synthesis of the VAPOL ligand that avoids the use of a chromium carbene complex, a route vias examined that involved the annulation of a naphthalene carboxamide via the method of Snieckus. The latter derivatives could be converted in a two-step sequence to 2-phenyl-4-phenanthrols in 6D-72% overall yields. The utility of this method for the synthesis of VAPOL derivatives is demonstrated in the synthesis of (S)-7,7'-dimethyl-VAPOL.

  DOI：

  10.1021/ol047852e
• 作为产物：
  描述：

  6-甲基萘-1-羧酸 在 氯化亚砜 、 N,N-二甲基甲酰胺 作用下， 以 苯 为溶剂， 反应 4.0h， 以96%的产率得到6-甲基-1-萘甲酰氯
  参考文献：
  名称：

  New Synthesis of Vaulted Biaryl Ligands via the Snieckus Phenol Synthesis

  摘要：

  In an effort to develop a synthesis of the VAPOL ligand that avoids the use of a chromium carbene complex, a route vias examined that involved the annulation of a naphthalene carboxamide via the method of Snieckus. The latter derivatives could be converted in a two-step sequence to 2-phenyl-4-phenanthrols in 6D-72% overall yields. The utility of this method for the synthesis of VAPOL derivatives is demonstrated in the synthesis of (S)-7,7'-dimethyl-VAPOL.

  DOI：

  10.1021/ol047852e

文献信息

• Heterocyclic derivatives
  申请人：Imperial Chemical Industries PLC

  公开号：US05098930A1

  公开（公告）日：1992-03-24

  The invention concerns a heterocyclic derivative of the formula I, ##STR1## wherein Ar.sup.1 is optionally substituted phenyl or naphthyl; A.sup.1 is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo-(3-6C)alkylene; Ar.sup.2 is optionally substituted phenylene, or a 6 membered heterocyclene moiety containing up to three nitrogen atoms; R.sup.1 is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and R.sup.2 and R.sup.3 together form a group of the formula -A.sup.2 -X-A.sup.3 - wherein each of A.sup.2 and A.sup.3 is (1-4C)alkylene and X is oxy, thio, sulphinyl, sulphonyl or imino; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  该发明涉及式I的杂环衍生物，其中Ar.sup.1是可选择取代的苯基或萘基；A.sup.1是(1-6C)烷基，(3-6C)烯基，(3-6C)炔基或环-(3-6C)烷基；Ar.sup.2是可选择取代的苯基，或含有最多三个氮原子的6元杂环基；R.sup.1是氢，(1-6C)烷基，(3-6C)烯基，(3-6C)炔基，氰基-(1-4C)烷基或(2-4C)烷酰基，或可选择取代的苯甲酰基；而R.sup.2和R.sup.3共同形成式-A.sup.2-X-A.sup.3-的基团，其中A.sup.2和A.sup.3中的每一个是(1-4C)烷基，X是氧，硫，亚硫酰基，磺酰基或亚胺基；或其药用可接受盐。该发明的化合物是5-脂氧合酶的抑制剂。
• Tetrahydrofuran derivatives
  申请人：Imperial Chemical Industries PLC

  公开号：US05234950A1

  公开（公告）日：1993-08-10

  The invention concerns a heterocyclic derivative of the formula I, ##STR1## wherein Ar.sup.1 is optionally substituted phenyl or naphthyl; A.sup.1 is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo-(3-6C)alkylene; Ar.sup.2 is optionally substituted phenylene, or a 6 membered heterocyclene moiety containing up to three nitrogen atoms; R.sup.1 is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and R.sup.2 and R.sup.3 together form a group of the formula --A.sup.2 --X--A.sup.3 -- wherein each of A.sup.2 and A.sup.3 is (1-4C)alkylene and X is oxy, thio, sulphinyl, sulphonyl or imino; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  本发明涉及公式I的杂环衍生物，其中Ar.sup.1是可选取代的苯基或萘基；A.sup.1是(1-6C)烷基，(3-6C)烯基，(3-6C)炔基或环-(3-6C)烷基；Ar.sup.2是可选取代的苯基，或含有最多三个氮原子的6元杂环基；R.sup.1是氢，(1-6C)烷基，(3-6C)烯基，(3-6C)炔基，氰基-(1-4C)烷基或(2-4C)酰基，或可选取代的苯甲酰基；R.sup.2和R.sup.3共同形成公式--A.sup.2--X--A.sup.3--的基团，其中每个A.sup.2和A.sup.3是(1-4C)烷基，X是氧，硫，亚磺酰基，磺酰基或亚胺基；或其药学上可接受的盐。本发明化合物是5-脂氧合酶酶的抑制剂。
• Ananthakrishnanadar, P.; Varghesedharumaraj, G., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1983, vol. 22, # 5, p. 506 - 507
  作者：Ananthakrishnanadar, P.、Varghesedharumaraj, G.

  DOI：——

  日期：——
• US5098930A
  申请人：——

  公开号：US5098930A

  公开（公告）日：1992-03-24
• US5234950A
  申请人：——

  公开号：US5234950A

  公开（公告）日：1993-08-10